Basics Axon Holdings S.A. Axovant Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of dementia. IPO Date: June 11, 2015 Sector: Industrials Industry: Aerospace and Defense Market Cap: $55.51B Activated in VL: True Average Daily Range Avg Daily Range: $2.91 | 2.41% Avg Daily Range (30 D): $12.25 | 1.68% Avg Daily Range (90 D): $12.82 | 1.68% Institutional Daily Volume Avg Daily Volume: .6M Avg Daily Volume (30 D): .43M Avg Daily Volume (90 D): .46M Trade Size Avg Trade Size (Sh.): 71 Avg Trade Size (Sh.) (30 D): 18 Avg Trade Size (Sh.) (90 D): 18 Institutional Trades Total Inst.Trades: 3,301 Avg Inst. Trade: $15.39M Avg Inst. Trade (30 D): $45.68M Avg Inst. Trade (90 D): $41.68M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $26.63M Avg Closing Trade (30 D): $70.77M Avg Closing Trade (90 D): $68.05M Avg Closing Volume: 85.1K     News Oct 22, 2025 @ 8:10 AM 5 Stocks That Could Create Lasting Generational We... Source: Justin Pope Oct 19, 2025 @ 11:15 AM The 5 Best-Performing S&P 500 Stocks of the Last D... Source: Selena Maranjian Oct 7, 2025 @ 10:17 AM 3 Growth Stocks to Invest $1,000 In Right Now Source: Rick Munarriz Sep 27, 2025 @ 9:30 AM Axon's Emergency AI Acquisition Source: Travis Hoium Sep 22, 2025 @ 2:34 PM Which Stocks Win When Rates Fall? Goldman Picks Th... Source: Piero Cingari Financials   TTM Q1 2025 Q3 2024 Basic EPS $.46 $1.14 $.89 Diluted EPS $.44 $1.08 $.86 Revenue $ 668.54M $ 603.63M $ 544.27M Gross Profit $ 403.74M $ 365.74M $ 330.75M Net Income / Loss $ 36.12M $ 87.98M $ 67.03M Operating Income / Loss $ -1.04M $ -8.79M $ 24.08M Cost of Revenue $ 264.8M $ 237.89M $ 213.53M Net Cash Flow $ -477.3M $ 638M $ 128.84M PE Ratio 1,666.85     Splits Sep 28, 2007:   1:600 Nov 30, 2004:   2:1 Apr 30, 2004:   2:1 Feb 11, 2004:   3:1